OMC
APLT

Old Mission Capital’s Applied Therapeutics APLT Stock Holding History

Old Mission Capital’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-8,903
Closed -$322K – 432
2020
Q2 		$322K Buy
+8,903
New +$373K 0.02% 319

Other funds holding APLT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Old Mission Capital's APLT Position: Q3 2020 in Review

Old Mission Capital sold out of Applied Therapeutics (APLT) in Q3 2020, closing a stake of 8,903 shares — an estimated $322K sold.

Old Mission Capital first reported a position in APLT in Q2 2020 and held it in 1 quarter. The position peaked at $322K in Q2 2020. 66 funds tracked by Wall St. Rank hold APLT as of Q3 2020.

  • Old Mission Capital reported no remaining Applied Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Old Mission Capital sold 8,903 Applied Therapeutics shares in Q3 2020, an estimated $322K.
  • Old Mission Capital first reported a position in Applied Therapeutics in Q2 2020 and held it in 1 quarter.
  • Old Mission Capital's Applied Therapeutics position peaked at $322K in Q2 2020.
  • 66 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2020.

Based on Old Mission Capital's 13F filing for Q3 2020, filed 16 Nov 2020.